Sign in
Taking people in United StatesNo phase

How kidney and urinary tract cancers use nutrients, studied during surgery or biopsy

Studies how kidney and urothelial cancers use nutrients, in adults having surgery or biopsy.

Key facts

Who runs it
University of Texas Southwestern Medical Center
Where
Dallas, United StatesSee the site
Trial code
Registry title
An Investigation of Kidney and Urothelial Tumor Metabolism in Patients Undergoing Surgical Resection and/or Biopsy
Status
Recruiting
People taking part
600 people, planned
Started
30 Sept 2019
Expected to end
30 Sept 2027
Type of study
Interventional, 5 groups
Treatments tested
  • 13C-Glucose
  • 13C-Acetate
  • 13C-Lactate
  • 13C-Glutamine
  • 13C-Fructose
Record updated
28 January 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with known or probable kidney or urothelial cancer who need a surgical biopsy or surgery. It studies how these tumors use nutrients.

Age
18 years or older
Sex
All sexes can join
Disease stage
Known or probable kidney or urothelial cancer seen on imaging, needing a surgical biopsy or removal
Earlier treatment
Taking part in other clinical trials is allowed; the study doctor decides case by case

Main reasons for not taking part

  • Uncontrolled or poorly controlled diabetes, for people getting a 13C infusion
  • Pregnant or breastfeeding
  • Cannot have surgery

The registry criteria, word for word

Show all 8 criteriaShow less

Who can take part

  • Patients must have radiographic evidence of known or probable kidney or urothelial cancer requiring surgical biopsy or excision
  • Age ≥ 18 years
  • Subjects of all races and ethnic origins
  • The willingness to sign and ability to understand a written informed consent
  • Patients participating in other clinical trials are eligible, and will be evaluated on a case by case basis by the Principal Investigator, Dr. Vitaly Margulis, MD

Who cannot take part

  • Uncontrolled or poorly controlled diabetes for patients receiving a 13C infusion
  • Not a surgical candidate
  • Pregnant or breastfeeding

Where in United States

  • University of Texas Southwestern Medical CenterDallas, United StatesContact: Vitaly MargulisTaking people

About the trial

What the trial wants to find out

The purpose of this study is to understand the metabolism of cancers involving the kidney, including renal cell carcinomas and urothelial cell carcinomas, and how kidney cancers use different types of fuel to support tumor growth. This study uses specially labeled nutrient tracers of compounds normally found circulating in the blood. The nutrients (glucose, fructose, glutamine, acetate, and lactate) are also found in common foods. A nutrient tracer will be given to the participants through an intravenous (IV) catheter during surgery or biopsy, and blood will be collected every 30 minutes during the infusion to monitor safety parameters and the nutrient tracers. The investigators will collect a tissue sample after the completion of surgery. Participants not having an infusion will have their tissue collected after surgery or biopsy.

Read full original descriptionShow less

Participation in this study will not change patient care. All patients will receive standard of care treatment as determined by their doctors.

The 5 groups in the trial

  • 13C-GlucoseTreatment being tested
  • 13C-AcetateTreatment being tested
  • 13C-LactateTreatment being tested
  • 13C-GlutamineTreatment being tested
  • 13C-FructoseTreatment being tested

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
An Investigation of Kidney and Urothelial Tumor Metabolism in Patients Undergoing Surgical Resection and/or Biopsy
Plain-language title
How kidney and urinary tract cancers use nutrients, studied during surgery or biopsyGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Record updated
28 January 2026